SE7906272L - Sett att framstella en immunglobulinlosning - Google Patents

Sett att framstella en immunglobulinlosning

Info

Publication number
SE7906272L
SE7906272L SE7906272A SE7906272A SE7906272L SE 7906272 L SE7906272 L SE 7906272L SE 7906272 A SE7906272 A SE 7906272A SE 7906272 A SE7906272 A SE 7906272A SE 7906272 L SE7906272 L SE 7906272L
Authority
SE
Sweden
Prior art keywords
degrees
solns
soln
sio2
damp
Prior art date
Application number
SE7906272A
Other languages
English (en)
Inventor
K Bunnig
Original Assignee
Blutspendedienst Des Landesver
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blutspendedienst Des Landesver filed Critical Blutspendedienst Des Landesver
Publication of SE7906272L publication Critical patent/SE7906272L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE7906272A 1978-08-25 1979-07-23 Sett att framstella en immunglobulinlosning SE7906272L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782837168 DE2837168A1 (de) 1978-08-25 1978-08-25 Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung

Publications (1)

Publication Number Publication Date
SE7906272L true SE7906272L (sv) 1980-02-26

Family

ID=6047909

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7906272A SE7906272L (sv) 1978-08-25 1979-07-23 Sett att framstella en immunglobulinlosning

Country Status (7)

Country Link
US (1) US4322403A (sv)
JP (1) JPS5547627A (sv)
AT (1) AT368886B (sv)
DE (1) DE2837168A1 (sv)
FR (1) FR2433946A1 (sv)
GB (1) GB2032437B (sv)
SE (1) SE7906272L (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
US4465670A (en) * 1982-07-23 1984-08-14 Dainippon Pharmaceutical Co., Ltd. Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor
DE3310150A1 (de) * 1983-03-21 1984-09-27 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
EP0973384A4 (en) * 1997-02-13 2004-10-13 Sky High Llc ORGAN PRESERVATION SOLUTION
US6962700B1 (en) 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
EP1909831A4 (en) 2005-06-14 2013-02-20 Amgen Inc PREPARATIONS OF SPONTANEOUS TAMPING PROTEINS
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
US20100278935A1 (en) * 2007-07-30 2010-11-04 Stacey William C Immune System Modulator Formulation
US20180110856A1 (en) 2016-10-21 2018-04-26 Amgen Inc. Pharmaceutical Formulations and Methods of Making the Same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6702923A (sv) * 1966-04-06 1967-10-09
US3449316A (en) * 1967-03-03 1969-06-10 American Cyanamid Co Process for the purification of gamma globulin employing bentonite
DE1792555C3 (de) * 1968-09-19 1980-01-10 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung einer für die intravenöse Anwendung geeigneten Gammaglobulinlösung
IL34079A (en) * 1969-04-01 1973-02-28 Upjohn Co Purification of ypsilon-globulins
US3607857A (en) * 1970-03-03 1971-09-21 Upjohn Co Process of removing acrinol from gamma globulin using siliceous material such as silica gel
FR2267115B1 (sv) * 1974-04-12 1977-11-10 Merieux Inst
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin

Also Published As

Publication number Publication date
AT368886B (de) 1982-11-25
DE2837168A1 (de) 1980-03-06
FR2433946A1 (fr) 1980-03-21
ATA505279A (de) 1982-04-15
JPS5547627A (en) 1980-04-04
GB2032437B (en) 1982-10-27
GB2032437A (en) 1980-05-08
US4322403A (en) 1982-03-30

Similar Documents

Publication Publication Date Title
SE7906272L (sv) Sett att framstella en immunglobulinlosning
DK0648127T3 (da) Type I- og type II-overfladeantigener associeret med Staphylococcus epidermidis
LU91610I2 (fr) Protéine D et ses dérivés pharmaceutiquement acceptables (SYNFLORIX - Vaccin pneumococcique polysaccharidique conjugé (adsorbé)
MX9101274A (es) Analogos de anillos fusionados de heterociclos no aromaticos nitrogenados
DE69127694D1 (de) Herstellung und verwendung von transfer-faktor
FI844596A0 (fi) Foerfarande foer framstaellning av oligosackarid-innehaollande produkter ur biomassa, produkter innehaollande oligosackarid samt deras anvaendning.
FI98067C (sv) Nya alkylendiammoniumdiklavulanataderivat, förfarande för deras framställning samt deras användning för rening av klavulansyra
AU7370491A (en) 2,8-dioxabicyclo(3,2,1)octane derivatives,their production from cultures of MF 5447 and MF 5466 and their use as anti hyper cholesterolemics
FI945323A0 (sv) 5-metyluridinförfarande för framställning av 2',3'-didehydro-3'-deoxitymidin (d4T) i stor skala
CA2065414A1 (en) Treatment of autoimmune disease
ATE154754T1 (de) Verfahren zur herstellung von pvp-h202-produkten
SE8005399L (sv) Framstellning av sampolymerer av propen och but-1-en
FR2342733A1 (fr) Derives de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
FR2643371B1 (fr) Nouveaux derives de l'acide 2-amino pentanedioique, leur procede de preparation et leur application comme medicaments
EP0441395A3 (en) Human monoclonal antibody and pharmaceutical composition containing the same for the treatment of pseudomonas infections
DE69322235D1 (de) Thiomarinol-Derivate und Verfahren zu ihrer Herstellung
FR2340093A1 (fr) Derives de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
OA04770A (fr) Nouveaux dérivés d'acide carbonique de 2-mercapto-4,5-dichlorothiazole, leur procédé de préparation et leur application comme herbicides.
CA2062105A1 (en) Purified mite allergen
FI901710A0 (sv) Förfarande för framställning av en antibakteriell kristallin (5R,6S)-2-karbamoyloximetyl-6-/(1R)-hydroxietyl/-2-penem-karboxylsyra
ATE15803T1 (de) Cephalosporinderivate, ihre herstellung und anwendung.
FR2608153B1 (fr) Di-bishydroxypropyle de l'acide cyanurique, ses derives trisubstitues et leur procede de fabrication
SU1273977A1 (ru) Способ моделировани сепсиса
Reddy et al. Bacteriological studies in healthy eyes and corneal ulcers.
Senko Status psychotherapy as the method of correction of the child's status in the kindergarten group

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7906272-5